Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8

European Respiratory Journal

Volumn 22, Issue 3, 2003, Pages 403-407

  Bull, T M ^a   Cool, C D ^b   Serls, A E ^b   Rai, P R ^b   Parr, J ^b   Neid, J M ^b   Geraci, M W ^a   Campbell, T B ^b   Voelkel, N F ^a   Badesch, D B ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Endothelial cell; Human herpesvirus 8; Plexiform lesion; Primary pulmonary hypertension

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; PROSTACYCLIN;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CARDIOMEGALY; CASE REPORT; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; LUNG PARENCHYMA; LYMPHADENOPATHY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYMPTOM; THORAX RADIOGRAPHY;

ADULT; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HEART CATHETERIZATION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; LUNG; LYMPH NODES; MALE; POLYMERASE CHAIN REACTION;

EID: 10744230194     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00006903     Document Type: Article

References (22)

1. Archer S, Rich S. Primary pulmonary hypertension: a vascular biology and translational research "work in progress". Circulation 2000; 102: 2781-2791.
2. Tuder RM, Cool CD, Yeager M, Taraseviciene-Stewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension. Endothelium. Clin Chest Med 2001; 22: 405-418.
3. Voelkel NF, Cool C, Lee SD, Wright L, Geraci MW, Tuder RM. Primary pulmonary hypertension between inflammation and cancer. Chest 1998; 114: 225S-230S.
4. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998; 101: 927-934.
5. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001; 88: E2-E11.
6. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998; 128: 657-662.
7. Nishi J, Maruyama I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma 2000; 38: 387-394.
8. Winter SS, Howard TA, Ritchey AK, Keller FG, Ware RE. Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's disease. Med Pediatr Oncol 1996; 26: 48-53.
9. Eddahibi S, Humbert M, Sediame S, et al. Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med 2000; 162: 1493-1499.
10. Voelkel NF, Hoeper M, Maloney J, Tuder RM. Vascular endothelial growth factor in pulmonary hypertension. Ann N Y Acad Sci 1996; 796: 186-193.
11. Belec L, Mohamed AS, Authier FJ, et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood 1999; 93: 3643-3653.
12. Pellicelli AM, Barbaro G, Palmieri F, et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology 2001; 52: 31-41.
13. Seoane L, Shellito J, Welsh D, de Boisblanc BP. Pulmonary hypertension associated with HIV infection. South Med J 2001; 94: 635-639.
14. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) 1980; 59: 311-322.
15. Izawa T, Fukata Y, Kimura T, Iwamatsu A, Dohi K, Kaibuchi K. Elongation factor-1alpha is a novel substrate of rho-associated kinase. Biochem Biophys Res Commun 2000; 278: 72-78.
16. Lesprit P, Godeau B, Authier FJ, et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med 1998; 157: 907-911.
17. Pan L, Milligan L, Michaeli J, Cesarman E, Knowles DM. Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn 2001; 3: 32-38.
18. White IE, Campbell TB. Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J Clin Microbiol 2000; 38: 1992-1995.
19. Simpson GR, Schulz TF, Whitby D, et al. Prevelence of Kaposi's sarcoma assoicated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 1133-1138.
20. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P. Biology of Kaposi's sarcoma. Eur J Cancer 2001; 37: 1251-1269.
21. Casper C, Krantz E, Taylor H, et al. Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection. J Clin Microbiol 2002; 40: 3822-3825.
22. Tedeschi R, Dillner J, De Paoli P. Laboratory diagnosis of human herpesvirus 8 infection in humans. Eur J Clin Microbiol Infect Dis 2002; 21: 831-844.